ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,224.46
0.55%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,335.135
0.32%
Brent Oil
85.815
0.47%
Bitcoin
61,609.10
0.00%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) News

Adicet Bio (ACET)

Adicet Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACET
DateTimeSourceHeadlineSymbolCompany
24/06/202412:00Business WireAdicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell CarcinomaNASDAQ:ACETAdicet Bio Inc
07/06/202421:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202421:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202421:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202421:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
05/06/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
05/06/202412:00Business WireAdicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus NephritisNASDAQ:ACETAdicet Bio Inc
31/05/202422:41Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
29/05/202412:00Business WireAdicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare ConferenceNASDAQ:ACETAdicet Bio Inc
14/05/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
14/05/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
14/05/202421:01Business WireAdicet Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
14/05/202415:00Business WireAdicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid CongressNASDAQ:ACETAdicet Bio Inc
10/05/202411:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
07/05/202412:00Business WireAdicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:ACETAdicet Bio Inc
30/04/202422:10Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
22/04/202421:30Business WireAdicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:ACETAdicet Bio Inc
08/04/202412:00Business WireAdicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
28/03/202421:19Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
19/03/202420:10Business WireAdicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:ACETAdicet Bio Inc
11/03/202411:00Business WireAdicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
01/03/202400:46Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
05/02/202421:01Business WireAdicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:ACETAdicet Bio Inc
02/02/202416:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACETAdicet Bio Inc
31/01/202421:39Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
27/01/202400:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
27/01/202400:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
25/01/202421:01Business WireAdicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ACETAdicet Bio Inc
 Showing the most relevant articles for your search:NASDAQ:ACET

Your Recent History

BOV
PLPL3
Plano & Plano Desenvolvi... ON
BOV
SOND6F
SONDOTECNICA PNB
BIT
P1WKP2
NLBNPIT1WKP2 20351221 21...
TG
DAIC
Daimler
GATE
JSTUSDT
JUST
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved